Blockchain Registration Transaction Record

REMSleep Secures Medicare Coding Approval for DeltaWave Sleep Therapy System

REMSleep receives Medicare PDAC coding approval for DeltaWave nasal pillow system, enabling insurance reimbursement and nationwide distribution for sleep apnea therapy across all care settings.

This development significantly impacts millions of Americans suffering from sleep apnea and other respiratory conditions who rely on CPAP and BiPAP therapy. With Medicare and private insurance reimbursement now secured for all DeltaWave configurations, patients gain access to a more versatile and potentially more comfortable nasal pillow system without facing prohibitive out-of-pocket costs. For healthcare providers, this eliminates billing uncertainties and expands treatment options, particularly for the 20-30% of CPAP patients who struggle with initial mask failure. The expanded FDA clearance covering multiple care environments means patients can maintain continuity of care from sleep laboratories to home settings, potentially improving therapy adherence and health outcomes. In a market where comfort and compliance are critical challenges, this regulatory breakthrough enables broader adoption of a solution that addresses specific patient needs identified through real-world feedback.